Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive dyskinesia.

Karla Soares-Weiser1, Hubert H Fernandez

  • 1Enhance Reviews, Kfar-Saba, Israel.

Seminars in Neurology
|March 29, 2007
PubMed
Summary
This summary is machine-generated.

Current research on tardive dyskinesia (TD) treatments reveals no definitive therapy. Clinicians must carefully assess the risks and benefits of available interventions for managing TD symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renewed mandate for Schools of Public Health: a call to action.

BMJ public health·2026
Same author

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.

JAMA neurology·2026
Same author

Closing the Gate Before the Horse is out of the Barn: A Model to Effectively Predict the First Fall in Patients with Parkinson's Disease.

Movement disorders clinical practice·2026
Same author

Phosphorylated alpha-synuclein skin biopsy alters diagnosis in two out of three patients: Initial findings in a tertiary center.

Parkinsonism & related disorders·2026
Same author

Data-driven neurobiological subtyping of Parkinson's disease using diffusion MRI-derived isotropic diffusion.

Neuroradiology·2026
Same author

Persistent Head Tremor Improvement in Essential Tremor Patients after Bilateral Ventral Intermediate Nucleus DBS.

Movement disorders clinical practice·2025
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Tardive dyskinesia (TD) is a complex neurological disorder characterized by involuntary movements.
  • Effective treatment options for TD remain a significant clinical challenge.

Purpose of the Study:

  • To provide an up-to-date review of clinical manifestations, pathophysiology, and evidence-based treatments for tardive dyskinesia.
  • To synthesize findings from randomized clinical trials evaluating interventions for neuroleptic-induced TD.

Main Methods:

  • Comprehensive literature search of Cochrane Library, EMBASE, and Medline.
  • Inclusion of 45 randomized clinical trials comparing active interventions against placebo for TD.
  • Independent data extraction and quality appraisal by two reviewers.

Main Results:

Related Experiment Videos

  • Over 90 different interventions for TD were evaluated across more than 500 randomized trials.
  • None of the reviewed trials identified a definitive therapeutic agent for TD.
  • Pooled analyses did not establish a universally effective treatment.

Conclusions:

  • No single intervention has emerged as a definitive therapy for tardive dyskinesia.
  • Clinical decision-making requires careful consideration of the risk-benefit profile for each patient and intervention.
  • Further research is needed to identify more effective and safer TD treatments.